Be Biopharma Announces First Scientific Disclosures and New Preclinical Data Supporting the Advancement of B Cell Medicines at the American Society of Gene & Cell Therapy 26th Annual Meeting May 3, 2023
XyloCor Gene Therapy Hits Goals, Paving Way for Phase 3 in Cardiovascular Space with no Current Treatment January 27, 2023
New CRISPR Startup, Drawing Big-Name Backers, Seeks to Fix Diseases Caused by Large DNA Errors September 20, 2022
